What sector does Medix Inc. belong to?

Medix Inc. operates in the Industrials sector, specifically the Services industry, and is listed on the US markets.

What is the current share price of 331A?

As of the latest available quote, 331A traded at ¥487.00. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of 331A?

Medix Inc. has a price-to-earnings (P/E) ratio of about 8.55. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of 331A?

The market capitalisation of Medix Inc. is approximately ¥3.79B.

Is Medix Inc. profitable?

For its latest reported financial year, Medix Inc. recorded a net profit margin of about 10.27%.

Does 331A pay a dividend?

Medix Inc. currently has a dividend yield of about 3.71%.

What is the return on equity (ROE) of 331A?

Medix Inc. has a return on equity (ROE) of about 12.70%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of 331A?

Over the past 52 weeks, 331A has traded between a low of ¥460.00 and a high of ¥575.00.

Medix Inc.

331A TSE Industrials Services

TSE Standard

¥487.00

+0.41%

Delayed · cached 15 min

Fair value analysis

331A

Medix Inc.

¥487.00

Close used for this calculation

¥987.48Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

79/100

Profitability21/25

Returns18/25

Balance Sheet15/25

Efficiency25/25

Growth25/25

Strong

Quality radar

Consensus fair value

¥987.48

Below FV

▲ +102.8% against the close used

Model range ¥553.62 – ¥1,684.80

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear¥553.62Fair value¥987.48Bull¥1,684.80

FairClose

52-week traded range

52W low ¥468.0052W high ¥559.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading below the consensus fair value

Medix Inc. closed at ¥487.00, 50.7% below the consensus fair value of ¥987.48 drawn from 9 valuation models.

Financial DNA score 79/100 — Strong. P/E of 8.7x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

¥553.62

+13.7%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=9%, r=10%, tg=3%, n=10yr

Graham Number

¥751.37

+54.3%

√(22.5 × EPS × BVPS)

EPS=56.16, BVPS=446.79

P/E Fair Value

¥1,123.20

+130.6%

EPS × 20x (sector P/E)

EPS=56.16, Sector P/E=20x

Peter Lynch (PEG)

¥1,684.80

+246.0%

EPS × Growth% (PEG = 1 is fair)

EPS=56.16, g=30%

EV/EBITDA

¥1,560.74

+220.5%

(EBITDA × 18x − Net Debt) ÷ Shares

EBITDA=709.86M

Dividend Discount (DDM)

¥973.03

+99.8%

D1 ÷ (r − g) where D1 = D0×(1+g)

D0=18.02, r=10%, g=8%

Book Value (P/B)

¥748.37

+53.7%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=446.79, ROE=12.7%, g=6%, r=10%

Reverse DCF

¥487.00

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: -4.3% | Historical: 34.3%

Margin of Safety

¥607.05

+24.7%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=809.4, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer